Möchten Sie immer auf dem neuesten Stand bleiben?

Oslo, Norway, 26 May 2016: Photocure ASA announces today that its Chief Operating Officer, Kathleen Deardorff, has resigned effective 1 June 2016 to pursue other career opportunities. Ms Deardorff...

Reference is made to the announcement on 23 May 2016 in respect of a capital increase of 34 134 new shares following exercise of employee share options in the company. The share capital increase has...

The board of directors of Photocure ASA has resolved a share capital increase as a consequence of employees exercising vested options granted under the company's employee incentive scheme. Upon...

Oslo, Norway, 10 May 2016: Photocure (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, announces its results for the first quarter 2016. ...

Oslo, Norway, May 9, 2016 -- Photocure ASA announced today new data from a prospective multicenter ongoing registry study that shows Blue Light Cystoscopy (BLC) with Cysview® increases detection...

Photocure will present its first quarter report on Tuesday 10 May 2016 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be...

Oslo, Norway, May 2, 2016: Photocure ASA announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016...

Oslo, Norway, 28 April, 2016. The Annual General Meeting in Photocure ASA took place on 28 April, 2016. A new Board of Directors was elected and consists of the following members until next...

Oslo, 27 April 2016: Photocure ASA (OSE: PHO). Reference is made to the stock exchange release disclosed 26 April 2016, regarding proxies received by Bente-Lill Bjerkelund Romøren in connection...

 Oslo, 26 April 2016: Photocure ASA (OSE: PHO). Bente-Lill Bjerkelund Romøren has as chairperson of the board of directors of PHO received proxies to vote for 1,288,250 shares at the annual general...